Multimodality treatment of neuroendocrine tumors of the thymus

Thoracic and Cardiovascular Surgeon

Volumn 53, Issue 5, 2005, Pages 305-309

  Dosios, Theodosios ^a,d   Nikou, C C ^a   Toubanakis, C ^a   Filippides, T ^b   Papachristou, D ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d Division of Thoracic Surgery   (Greece)

Author keywords

Carcinoid; Mediastinum; Octreotide; Recurrence; Thymus

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANTINEOPLASTIC AGENT; CISPLATIN; ETOPOSIDE; OCTREOTIDE; PACLITAXEL; PENTETREOTIDE; SOMATOSTATIN DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIMODALITY CANCER THERAPY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; THYMOMA; TREATMENT OUTCOME; TUMOR DIAGNOSIS; TUMOR RECURRENCE;

ADULT; CARCINOID TUMOR; CARCINOMA, SMALL CELL; CHEMOTHERAPY, ADJUVANT; CHROMOGRANIN A; CHROMOGRANINS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROENDOCRINE TUMORS; PHOSPHOPYRUVATE HYDRATASE; RADIOTHERAPY, ADJUVANT; SURGICAL PROCEDURES, OPERATIVE; SYNAPTOPHYSIN; THYMUS NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 26944443665     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837706     Document Type: Article

References (21)

1. Chaer R, Massad MG, Evans A, Snow NJ, Geha AS. Primary neuroendocrine tumors of the thymus. Ann Thorac Surg 2002; 74: 1733-1740
2. Rosai J, Higa E, Davie J. Mediastinal endocrine neoplasm in patients with multiple endocrine adenomatosis: a previously unrecognized association. Cancer 1972; 29: 1075-1083
3. Rosai J, Sobin LH. World Health Organization International Histological Classification of Tumors: Histological Typing of Tumors of the Thymus. 2nd ed. Berlin: Springer Verlag, 1999: 15-18
4. Klemm K, Moran C. Primary neuroendocrine carcinomas of the thymus. Semin Diagn Pathol 1999; 16: 32-41
5. Floros D, Dosios T, Tsourdis A, Yiatromanolakis N. Carcinoid tumor of the thymus with multiple endocrine adenomatosis. Path Res Pract 1982; 175: 404-409
6. De Perrot M, Spiliopoulos A, Fischer S, Totsch M, Keshavjee S. Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing's syndrome. Ann Thorac Surg 2002; 73: 675-681
7. Moran C, Suster S. Neuroendocrine carcinomas (carcinoid tumors) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol 2000; 114: 100-110
8. Brown LR, Aughenbaugh GL, Wick MR, Baker BA, Salassa RM. Roentgenologic diagnosis of primary corticotropin-producing carcinoid tumors of the mediastinum. Radiology 1982; 142: 143-148
9. Soga J, Yakuwa Y, Osaka M. Evaluation of 342 cases of mediastinal/thymic carcinoids collected from literature: a comparative study between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 1999; 5: 285-292
10. Lokich JJ, Li F. Carcinoid tumor of the thymus with hereditary hyperparathyroidism. Ann Intern Med 1978; 89: 364-365
11. Marchevsky AM, Dikman SH. Mediastinal carcinoid with an incomplete Sipple's syndrome. Cancer 1979; 43: 2497-2501
12. Wick MR, Rosai J. Neuroendocrine neoplasms of the thymus. Path Res Pract 1988; 183: 188-189
13. John L CH, Hornick P, Lang S, Wallis J, Edmondson SJ. Giant thymic carcinoid. Postgrad Med J 1991; 67: 462-465
14. Economopoulos GC, Lewis JW, Lee MW, Silverman NA. Carcinoid tumors of the thymus. Ann Thorac Surg 1990; 50: 58-61
15. Gal AA, Kornstein MJ, Cohen C, Duerte IG, Miller JI, Mansour K. Neuroendocrine tumors of the thymus: A clinicopathological and prognostic study. Ann Thorac Surg 2001; 72: 1179-1182
16. Arnond R, Simon B, Wied M. Treatment of neuroendocrine GEP tumors with somatostatin analogues. Digestion 2000; 62 (Suppl): S84-S91
17. Errikson B, Oberg K. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumours. Ann Oncol 1999; 10 (Suppl): S31-S38
18. Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 2001; 12 (Suppl): S111-S114
19. Tomassetti P, Migliori M, Corinaldesi R, Gullo L. Treatment of gastroenteropancreatic neuroendocrine tumors with octreotide LAR. Aliment Pharmacol Ther 2000; 14: 557-560
20. Filosso PL, Ruffini E, Oliaro A, Papalia E, Donati G, Rena O. Long-term survival of atypical bronchial carcinoid with liver metastases, treated with octreotide. Eur J Cardiothorac Surg 2002; 21: 913-917
21. Filosso PL, Dato GMA, Ruffini E, Bretti S, Ozzello F, Mancuso M. Multidisciplinary treatment of advanced neuroendocrine carcinoma (carcinoid): Report of a successful case and review of the literature. J Thorac Cardiovasc Surg 2004; 127: 1215-1219